<DOC>
	<DOCNO>NCT00236405</DOCNO>
	<brief_summary>The purpose study compare effect perioperative administration PROCRIT autologous blood donation post-operative rehabilitation outcomes patient undergoing unilateral knee surgery .</brief_summary>
	<brief_title>PROCRIT Short-Term Outcomes Orthopedic Surgery</brief_title>
	<detailed_description>The primary objective study compare effect perioperative administration PROCRIT preoperative autologous donation post-operative rehabilitation outcome subject undergoing primary unilateral knee arthroplasty . Secondary objective : 1 ) To compare effect perioperative administration PROCRIT preoperative autologous donation hemoglobin , change hemoglobin , number unit transfuse transfusion rate study period ; 2 ) To compare effect perioperative administration PROCRIT preoperative autologous donation inpatient rehabilitation length stay . The study test hypothesis perioperative administration PROCRIT improve post-operative rehabilitation outcome , compare preoperative autologous donation . 40,000U PROCRIT Placebo SC relation surgery date : Days -21 , -14 , -7 , 0 ( day surgery ) , 7 , 14 .</detailed_description>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Scheduled primary unilateral knee arthroplasty expect discharge inpatient rehabilitation facility Hemoglobin &gt; 11 &lt; 13 g/dL screen preoperative day 21 Age 18 year old Female subject must postmenopausal least one year surgically sterile ( hysterectomy tubal ligation ) . Women childbearing age must negative pregnancy test ( ) ( serum HCG RIA screen urine preoperative day 21 , applicable Preoperative lead time least 21 day Medical condition include : Known iron deficiency ( define serum ferritin &lt; 50 mg/l ) chronic renal failure , significant hematological disease , uncontrolled hypertension , new onset seizures/uncontrolled seizure Expected need another low extremity major joint replacement within six month Undergoing cancer chemotherapy History thrombotic vascular event include limited stroke , transient ischemic attack , myocardial infarction deep venous thrombosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Anemia</keyword>
	<keyword>erythropoetin</keyword>
	<keyword>quality-of-life outcome</keyword>
</DOC>